Heidenhain variant of Creutzfeldt-Jakob disease masquerading as neuromyelitis optica spectrum disorder: recognizing when apheresis is not the answer
Burke O, Jacobs J, Tormey C, Rinder H, Villalba C, Lee E, Campos J, Abels E, Yurtsever N. Heidenhain variant of Creutzfeldt-Jakob disease masquerading as neuromyelitis optica spectrum disorder: recognizing when apheresis is not the answer. Lab Medicine 2023, 55: 520-523. PMID: 38142129, DOI: 10.1093/labmed/lmad107.Peer-Reviewed Original ResearchNeuromyelitis optica spectrum disorderCreutzfeld-Jakob diseaseOptica spectrum disorderHeidenhain variantBilateral vision lossTherapeutic plasma exchangeReal-time quaking-induced conversionCreutzfeldt-Jakob diseaseImmunosuppressive therapyVisual disturbancesPlasma exchangeNeurocognitive symptomsTreatment modalitiesVision lossHospice careSpectrum disorderRare formPreliminary diagnosisDiseaseDiagnosisDisordersEarly stagesPatientsApheresisTherapyImmunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease
Jacobs J, Villalba C, Stendahl K, Tormey C, Abels E. Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease. Journal Of Clinical Apheresis 2023, 38: 770-777. PMID: 37698143, DOI: 10.1002/jca.22088.Peer-Reviewed Original ResearchConceptsTherapeutic plasma exchangeAnti-glomerular basement membrane diseaseAnti-GBM diseasePlasma exchangeMembrane diseaseDaily therapeutic plasma exchangeFatal disseminated adenovirus infectionRare autoinflammatory conditionsMulti-organ failureStandard therapeutic regimenDisseminated adenovirus infectionDisseminated adenovirus diseasePotential opportunistic infectionsPotential adverse effectsApheresis guidelinesAdenovirus diseaseOrgan inflammationProfound immunosuppressionAutoantibody productionOpportunistic infectionsTherapeutic regimenAutoinflammatory conditionsImmunosuppressive chemotherapyUnusual infectionsClose surveillance